531592 — Genpharmasec Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹592.48m
- IN₹825.33m
- IN₹1.40bn
Annual cashflow statement for Genpharmasec, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.43 | 2.82 | 2.51 | 18.8 | 9.71 |
| Depreciation | |||||
| Non-Cash Items | -0.571 | -0.147 | 3.29 | -20.3 | -2.04 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -18.6 | -35.2 | -35.7 | 23.3 | -198 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -23.4 | -32.3 | -29.5 | 29.9 | -169 |
| Capital Expenditures | -0.805 | -0.16 | -0.184 | -57.1 | -5.21 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 4.99 | 5.54 | -280 | -95.9 | 138 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 4.18 | 5.38 | -281 | -153 | 133 |
| Financing Cash Flow Items | — | — | -3.75 | -6.26 | -10.5 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0 | 30.8 | 478 | -12.5 | 39.2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -19.3 | 3.85 | 168 | -136 | 3.24 |